Oral DNA Vaccination in Combination With Checkpoint Inhibitor In Recurrent Glioblastoma

Time: 5:15 pm
day: Day One

Details:

  • Cytotoxic T-cell approach targeting VEGFR-2 on tumor vasculature and tumor cells
  • Combination with checkpoint inhibitors
  • Intratumoral immune-biomarkers pre- and post treatment

Speakers: